| Excerpt | Relevance | Reference |
|---|
| " Tolerability was evaluated by laboratory results, vital signs and any adverse event occurring during the clinical trial, including presence or absence of somnolence." | 6.69 | Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. ( Barni, S; Daffonchio, L; Luporini, G; Marchi, E, 1998) |
| " Tolerability was evaluated by laboratory results, vital signs and any adverse event occurring during the clinical trial, including presence or absence of somnolence." | 2.69 | Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. ( Barni, S; Daffonchio, L; Luporini, G; Marchi, E, 1998) |